This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Retain Omnicom (OMC) in Portfolio Now
by Zacks Equity Research
Omnicom (OMC) rides on solid investor-friendly steps and organic growth initiatives.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio
by Zacks Equity Research
Insperity (NSP) puts consistent efforts to reward shareholders through share repurchases and dividends. Increasing expenses remain a concern.
5 Reasons to Add Gartner (IT) Stock to Your Portfolio Now
by Zacks Equity Research
Gartner's (IT) high-quality, timely, thought-provoking and comprehensive analysis offering helps it counter growing competition.
Here's Why Investors Should Buy ABM Industries (ABM) Now
by Zacks Equity Research
Strategic acquisitions and investor-friendly steps boost ABM Industries (ABM).
Reasons to Retain ICF International (ICFI) in Your Portfolio
by Zacks Equity Research
ICF International, Inc. (ICFI) is seeing solid growth in its service revenues driven by strength in IT modernization and digitization, disaster management and public health services.
Accenture (ACN) to Gain From Advocate Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) expand its technology business management capabilities.
Best Growth Stocks to Buy for June 7th
by Zacks Equity Research
IMO, LUV, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 7, 2022.
What's in the Cards for ABM Industries (ABM) in Q2 Earnings?
by Zacks Equity Research
ABM Industries' (ABM) second-quarter fiscal 2022 earnings and revenues are likely to have improved year over year.
Here is Why Growth Investors Should Buy Avis Budget (CAR) Now
by Zacks Equity Research
Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
Zacks.com featured highlights include Driven, Carlisle Companies, Avis, Sociedad Quimica y Minera, and Tenaris
by Zacks Equity Research
Driven, Carlisle Companies, Avis, Sociedad Quimica y Minera, and Tenaris are part of Zacks Screen of the Week article.
Accenture (ACN) to Gain From Greenfish Buyout: Here's How
by Zacks Equity Research
The latest deal is expected to strengthen Accenture's (ACN) sustainability services across Europe.
Reasons to Retain Stericycle (SRCL) Stock in Your Portfolio
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships in the form of long-term contracts ranging from three to five years.
Accenture (ACN) to Benefit From ARZ Acquisition: Here's How
by Zacks Equity Research
The latest deal is expected to help Accenture (ACN) broaden its banking platform-as-a-service capabilities across Europe.
Reasons to Retain Waste Management (WM) Stock in Your Portfolio
by Zacks Equity Research
Waste Management (WM) continues to execute core operating initiatives targeting focused differentiation and continuous improvement.
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Top Stocks Likely to Beat Earnings Estimates
by Sanghamitra Saha
Top-ranked stocks CAR, SQM, CSL, TS and DRVN are likely to beat on bottom line in their next releases.
Why Is Avis Budget (CAR) Down 33.3% Since Last Earnings Report?
by Zacks Equity Research
Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
6 Reasons to Buy Automatic Data Processing (ADP) Stock Now
by Zacks Equity Research
Acquisition strategy and initiatives to streamline and expand its business should drive Automatic Data Processing's (ADP) prospects.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
by Zacks Equity Research
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
6 Reasons to Add Avis Budget (CAR) Stock to Your Portfolio Now
by Zacks Equity Research
Acquisitions, technology enhancement and fleet expansion bode well for Avis Budget (CAR).
Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) solid business model, diversified products and services, and strategic acquisitions boost top-line growth.
Green Dot (GDOT) Rides on Prolonged Partnership With Walmart
by Zacks Equity Research
Time-honored relationship with Walmart boosts Green Dot (GDOT).
UiPath (PATH) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
UiPath's (PATH) first-quarter fiscal 2023 revenues are expected to have improved year over year, while earnings are likely to have declined.
Rollins' (ROL) Acquisitions Aid, Rising Expenses Ail
by Zacks Equity Research
Rollins (ROL) is a steady dividend payer with a balanced approach to organic and inorganic growth.
Reasons to Retain Rollins (ROL) Stock in Your Portfolio
by Zacks Equity Research
Rollins (ROL) is currently benefiting from strength in all of its business lines.